Drugs / clofazamine
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| — | NCT00852345 | — | leprosy | Kaiser Permanente | No longer available | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | clofazamine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00852345 ↗ |
| Route | Oral | “clofazamine 50mg po qday (duration varies according to physician)” NCT00852345 ↗ |